Studies of sublines selected for loss of HLA expression from an EBV-transformed lymphoblastoid cell line. Changes in sensitivity to cytotoxic T cells activated by allostimulation and natural killer cells activated by IFN or IL-2
- PMID: 2468716
Studies of sublines selected for loss of HLA expression from an EBV-transformed lymphoblastoid cell line. Changes in sensitivity to cytotoxic T cells activated by allostimulation and natural killer cells activated by IFN or IL-2
Abstract
Murine tumor studies have suggested that variations in MHC class I expression may influence the behavior of tumor cells in vivo. Corresponding human tumor studies remain at the descriptive level but they show differences in MHC Ag expression between and even within tumors. Our purpose was to explore possible functional relationships between class I expression and sensitivity to different forms of cell-mediated lysis in a potentially immunogenic system: EBV-immortalized B cells. Their cytotoxic sensitivity was tested to CTL and to IFN- or IL-2-activated effector cells. The wild-type line (high class I) was sensitive to CTL with the appropriate Ag restriction, but resisted lysis by normal or IFN-activated PBL. In contrast, HLA loss variants showed a reduced sensitivity to CTL and an increased NK sensitivity. The latter could be related to the loss of class I molecules: an intermediate (haplotype loss) expressor variant was moderately NK sensitive, whereas a weak expressor line, with an additional down-regulation of the remaining haplotype, was highly sensitive. IL-2-activated PBL ("LAK") cells showed the same killing pattern as NK cells, although the levels of lysis were generally higher. These data support the hypothesis that the MHC class I Ag expression-dependent, CTL-mediated lysis is complemented by additional mechanisms, mediated by effectors that recognize cells with reduced MHC Ag expression that would otherwise escape CTL-mediated rejection.
Similar articles
-
H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.J Immunol. 1988 Mar 15;140(6):2096-102. J Immunol. 1988. PMID: 3126240
-
The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum.Cell Immunol. 1994 Dec;159(2):246-61. doi: 10.1006/cimm.1994.1311. Cell Immunol. 1994. PMID: 7994757
-
Antigen-specific, but not natural killer, activity of T cell receptor-gamma delta cytotoxic T lymphocyte clones involves secretion of N alpha-benzyloxycarbonyl-L-lysine thiobenzyl ester serine esterase and influx of Ca2+ ions.J Immunol. 1989 Sep 1;143(5):1506-11. J Immunol. 1989. PMID: 2474601
-
Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.Crit Rev Immunol. 1993;13(1):1-34. Crit Rev Immunol. 1993. PMID: 8466640 Review.
-
Cytotoxic effector cells of the immune system.Anat Embryol (Berl). 1989;180(2):109-19. doi: 10.1007/BF00309762. Anat Embryol (Berl). 1989. PMID: 2679226 Review.
Cited by
-
Role of major histocompatibility complex class-I molecules in tumor rejection. New insights from studies with synthetic peptides and transgenic mice.Immunol Res. 1990;9(4):298-313. doi: 10.1007/BF02935529. Immunol Res. 1990. PMID: 2089075 Review. No abstract available.
-
Reduction in susceptibility to natural killer cell-mediated lysis of human FO-1 melanoma cells after induction of HLA class I antigen expression by transfection with B2m gene.J Clin Invest. 1991 Jul;88(1):282-9. doi: 10.1172/JCI115289. J Clin Invest. 1991. PMID: 1905328 Free PMC article.
-
Histocompatibility antigens and natural killer susceptibility.Immunol Res. 1992;11(2):133-40. doi: 10.1007/BF02918618. Immunol Res. 1992. PMID: 1431422 Review.
-
Loss or down-regulation of HLA class I expression at the allelic level in freshly isolated leukemic blasts.Cancer Sci. 2007 Jan;98(1):102-8. doi: 10.1111/j.1349-7006.2006.00356.x. Cancer Sci. 2007. PMID: 17083564 Free PMC article.
-
Driving adenovirus type 12-transformed BALB/c mouse cells to express high levels of class I major histocompatibility complex proteins enhances, rather than abrogates, their tumorigenicity.J Virol. 1992 May;66(5):2875-84. doi: 10.1128/JVI.66.5.2875-2884.1992. J Virol. 1992. PMID: 1313906 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Research Materials